Quick summaries of Episodes 31-40. 

31. Injection Drug Use Frequency Before and After Take-Home Naloxone Training 

32. Trazodone for sleep disturbance in opioid dependent patients maintained on buprenorphine: A double blind, placebo-controlled trial

33. Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mortality records 

34. Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl 

35. Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder 

36. Emotion dysregulation factors associated with problematic smartphone use severity: The mediating role of fear of missing out 

37. Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial 

38. Receipt of Opioid Use Disorder Treatments Prior to Fatal Overdoses and Comparison to No Treatment in Connecticut, 2016-17 

39. Effects of Abstinence From Opioid on Neuropsychological Performance in Men With Opioid Use Disorder: A Longitudinal Study 

40. Drug overdose risk with benzodiazepine treatment in young adults: Comparative analysis in privately and publicly insured individuals 

---

Credits

---

This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group. 

Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities. 

Learn more about your ad choices. Visit megaphone.fm/adchoices